These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 10589775

  • 1. A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.
    Chen WY, Ramamoorthy P, Chen N, Sticca R, Wagner TE.
    Clin Cancer Res; 1999 Nov; 5(11):3583-93. PubMed ID: 10589775
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
    Beck MT, Chen NY, Franek KJ, Chen WY.
    Cancer Res; 2003 Jul 01; 63(13):3598-604. PubMed ID: 12839947
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
    Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly PA, Goffin V.
    Oncogene; 2000 Sep 28; 19(41):4695-705. PubMed ID: 11032019
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice.
    Tomblyn S, Langenheim JF, Jacquemart IC, Holle E, Chen WY.
    Int J Oncol; 2005 Nov 28; 27(5):1381-9. PubMed ID: 16211235
    [Abstract] [Full Text] [Related]

  • 10. Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R.
    Beck MT, Peirce SK, Chen WY.
    Oncogene; 2002 Aug 01; 21(33):5047-55. PubMed ID: 12140755
    [Abstract] [Full Text] [Related]

  • 11. A Novel Mechanism of hPRL-G129R, a Prolactin Antagonist, Inhibits Human Breast Cancer Cell Proliferation and Migration.
    Li R, Yang Y, Lan H, Wang Y, Ge Z, Liu X, Zhou Y, Zhang W, Xian L, Yuan H.
    Endocrinology; 2023 Nov 02; 164(12):. PubMed ID: 37934803
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.
    Langenheim JF, Chen WY.
    Breast Cancer Res Treat; 2005 Apr 02; 90(3):281-93. PubMed ID: 15830142
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
    Gutzman JH, Miller KK, Schuler LA.
    J Steroid Biochem Mol Biol; 2004 Jan 02; 88(1):69-77. PubMed ID: 15026085
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stromal-epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer.
    Xu C, Langenheim JF, Chen WY.
    Breast Cancer Res Treat; 2012 Jul 02; 134(1):157-69. PubMed ID: 22270933
    [Abstract] [Full Text] [Related]

  • 19. Prolactin receptor antagonism in mouse anterior pituitary: effects on cell turnover and prolactin receptor expression.
    Ferraris J, Boutillon F, Bernadet M, Seilicovich A, Goffin V, Pisera D.
    Am J Physiol Endocrinol Metab; 2012 Feb 01; 302(3):E356-64. PubMed ID: 22094470
    [Abstract] [Full Text] [Related]

  • 20. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
    Reddel RR, Alexander IE, Koga M, Shine J, Sutherland RL.
    Cancer Res; 1988 Aug 01; 48(15):4340-7. PubMed ID: 3390830
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.